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ABSTRACT   Currently, breast conserving surgery has been adopted to treat more than half of 
all breast cancer patients in Japan. When performing breast-conserving surgery, an appropriate 
margin needs to be determined for radical cure. The resection volume influences the esthetic 
outcome, but a cancer-positive resection stump is also important risk factor of local recurrence. 
Additionally, the degree of cancer progression influences the surgical method, so understanding 
the appropriate resection margin is necessary for the surgeons. We report here on a 50-
year old patient whose intra-ductal cancer progression was shown, as predicted, by contrast 
SMI (superb micro-vascular imaging). A one-cm size tumor mass was palpable with a clear 
boundary. B-mode ultrasound confirmed the presence of a breast duct towards the nipple from 
the tumor mass. Using contrast SMI, an accelerated blood flow was detected around the duct, 
which suggested intra-ductal progression. The pathological results also showed intra-ductal 
progression to the nipple from the tumor. Around the progression area, a meandering vessel was 
found and the vessel was able to be visualized by contrast SMI.
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INTRODUCTION
   Both breast-conserving surgery and mastectomy 
are available to treat breast cancer, and currently 
breast-conserving treatment has been adopted to treat 
more than half of breast cancer patients in Japan１）. 
When performing breast-conserving surgery, the 
resection volume influences the esthetic outcome. 
In 2016, the American Society of Clinical Oncology 
(ASCO) published a report that any resected margin 
larger than 2 mm for treating noninvasive/intra-
ductal cancer using conserving treatment doesn’t 
contribute to life prognosis２）. When the intra-ductal 
cancer spread is detected and understood in mm 
level detail, the resected margin can be minimized 
for performing better breast-conserving surgeries. 
We report here a case in which contrast superb 
micro-vascular imaging (SMI) proved to be useful 
to diagnose the intra-ductal cancer spread.
Patient
   A fifty-year-old female. She discovered a tumor 
mass in her left breast and visited a doctor. She 
hadn’t had any prior medical check for breast 
cancer. 
Current medical history: A one-cm size tumor mass 
with good mobility was palpable in the upper inner 
quadrant of the left breast.
Mammography: Microlobulated round mass in the 
left M (middle) / O (outside) area. (Fig. 1)
Ultrasound: An 8 x 9 mm size irregular shaped 
tumor mass was found with an unclear boundary in 
the lower outer quadrant of the left breast. The inner 
echo was even and the tumor mass was hypoechoic 
(Fig. 2-1). The blood flow measured by Doppler 
ultrasound was moderate (Fig. 2-2). The duct 
was enlarged from the tumor to the nipple, which 
suggested intra-ductal progression, however, this 
site showed a red signal by elastography, and the 
cancer progression could not be confirmed (Fig. 
2-3). 0.0075ml/kg of Sonazoid was administered 
transvenously as an ultrasound contrast agent, which 
was flushed out with 10 ml of saline. The contrast 
SMI showed a meandering blood flow along the 
expanded duct site (Fig. 2-4).
Core Needle Biopsy: A finding of invasive 
ductal carcinoma. Having a fibrous stroma in the 
background, atypical cells infiltrated and proliferated 
in ductal and cribriform patterns. [ER (estrogen 
receptor) + (90%)], [PgR (progesterone receptor) 
+ (5%)], [HER-2 (human epidermal growth factor 
receptor type2) :2+, FISH (fluorescence in situ 
hybridization) － ], Ki-67 index 16%.
MRI: A 9 x 11 mm size tumor was found that had a 
rapid-washout of contrast effect in the upper inner 
quadrant of the left breast. Nodules were found in 
cords inside of the tumor mass (Fig. 3).
Preoperative diagnosis: Left breast cancer T1bN0M0 
Stage I.
Operation method: Due to the positive result of 
the intra-operative rapid diagnosis, the left breast 
quadrantectomy was changed to a mastectomy with 
a sentinel lymph-node biopsy.
Macroscopic finding of resected specimen: A 8 x 7 
mm size yellowish white nodule was found.
Pathology: Atypical cells infiltrated and proliferated 
in the fibrous connective tissues in the forms of 
cords, follicles and glandular ducts, thus diagnosed 
as scirrhous carcinoma. Also, the cancer cells 
progressed into a solid form, comedo type and 
cribriform from the area surrounding the tumor 
towards the nipple (Fig. 4-1, 2, 3). Venous invasion 
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Fig. 1  Microlobulated round mass in the left M/O area
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Fig. 2  An 8 x 9 mm size irregular shaped tumor mass was found with an unclear boundary in the A area of the left breast. 
Vascularity was moderate. The duct was enlarged from the tumor to the nipple, which suggested intraductal progression, however, 
this site showed a red signal by elastography, and the cancer progression could not be confirmed. The contrast SMI showed a 
meandering blood flow along the expanded duct site, and SMI didn’t show them.
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Fig. 3  A tumor was found that had a rapid-washout of contrast effect in the upper inner 
quadrant of the left breast. Nodules were found in cords inside of the tumor mass (Arrows).
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Fig. 4  Atypical cells infiltrated and proliferated in the fibrous connective tissues in the forms of cords, follicles and glandular 
ducts, thus diagnosed as scirrhous carcinoma. Also, the cancer cells progressed surrounding the tumor towards the nippl
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was found but no lymph duct invasion was 
found. Estrogen receptor was 100% positive and 
progesterone receptor was 5% positive. HER2 was 
2+ and Fish was negative. Ki67 was 15%.
   Intra-ductal progression was found from the tumor 
towards the nipple. A 100μm meandering vessel 
was found around the tumor which was the same 
vessel detected by contrast SMI (Fig. 5-1, 2, 3). Fig5-1  
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Fig. 5  1: Comparison of us image and pathological loupe image. 2, 3: Expanded within the flame of Fig. 5-1. Intra-ductal 
progression (Arrows) was found from the tumor towards the nipple same as vessel detected by contrast SMI.
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DISCUSSION
   Currently, breast-conserving surgery is being 
used for more than half of all breast cancer patients 
in Japan. When performing breast-conserving 
surgery, an appropriate margin needs to be 
determined for radical cure. The resection volume 
influences the esthetic outcome, but a cancer-
positive resection stump is also important risk 
factor of local recurrence. In addition, the degree of 
cancer progression influences the surgical method, 
so determining the appropriate resection margin 
is necessary for the surgeons. It is difficult to 
understand the intra-ductal cancer spread precisely 
including intra-ductal progression. MRI is useful 
for diagnosing the intra-ductal spread of breast 
cancer, however, the contrasted range of the intra-
ductal cancer spread could lead to overdiagnosis. 
Moreover, the patient’s body position at the time of 
the MRI and the time of surgery are different, so it 
is difficult to reproduce the same precise resection 
margin marking for surgery. Ultrasound is relatively 
simple to perform even during surgery, so ultrasound 
is necessary for marking.
   Tumor angiogenesis plays an important role 
in cancer growth and is also an independent 
prognosis factor for breast cancer３）. Blood flow in 
mammary ducts is usually evaluated with multiple 
modalities. Until recently, blood flow was evaluated 
using Doppler ultrasound and first generation 
ultrasound contrast agent, but observing precise 
and detailed tumor vessels proved difficult. Since 
2012, Sonazoid, which is a second generation 
ultrasound contrast agent, has been available, and 
now even slow blood flow can be evaluated which 
was difficult to image using conventional Doppler 
ultrasound. Sonazoid is comprise of microbubbles 
that are as small as a few microns in diameter, and it 
is delivered to the targeted organ by the circulatory 
system. Due to Sonazoid’s strong resonance and 
distribution in the blood, ultrasound signals can 
be greatly enhanced, and the evaluation of blood 
flow does not need to rely on blood flow speed. 
Also, SMI can eliminate motion artifacts that were 
an obstacle for the conventional evaluation of 
blood flow and can also capture ultra-low blood 
flow. Contrast enhanced ultrasound (CEUS) was 
reported to be superior to MRI in terms of precision 
of benignancy or malignancy distinction during 
the second and third phases of Sonazoid clinical 
trials４，５）. Currently, there are reports of CEUS 
on the diagnosis of intra-ductal cancer spread and 
therapy evaluation, not only the distinction between 
benignancy and malignancy６） and the same effect 
is expected with contrast SMI７）. Different from 
the enhancement effect of CEUS, contrast SMI can 
show vascular morphology sterically, which means 
it can show abnormal vascular morphology.
   At our hospital, all the breast cancer patients who 
undergo a contrast enhanced ultrasound receive 
(breast) marking the day before surgery. The surgical 
method is decided based on the MRI information. 
This patient was suspected of having intra-ductal 
progression. B-mode detected successive ducts 
from the tumor mass towards the nipple and only 
the contrast SMI was able to show the increased 
vascularity around the ducts. There was no major 
change in the normal ducts towards the body both 
before and after performing the contrast SMI. 
From the above facts, the clearly accelerated blood 
flow shown by Sonazoid could have been caused 
by abnormal blood vessels. A meandering blood 
vessel that was about 100μm long was running 
along the carcinoma according to the pathology 
results. Contrast SMI also predicted the intra-ductal 
progression. However, diagnosing only based on the 
blood flow could lead to an overdiagnosis of intra-
ductal progression of a carcinoma and/or papilloma. 
Nakashima et al. reported that comprehensive 
ultrasound diagnosis８，９） can detect an intra-ductal 
lesion that is larger than 2 mm using elastography. 
By adding a contrast SMI, a more precise diagnosis 
can be expected. 
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CONCLUSION
   We experienced a case in which contrast SMI was 
useful for evaluating intra-ductal progression. 
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